SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-024906
Filing Date
2022-05-09
Accepted
2022-05-09 17:00:35
Documents
13
Period of Report
2022-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159623-8k425_biotech.htm   iXBRL 8-K 52056
  Complete submission text file 0001213900-22-024906.txt   286523

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biot-20220503.xsd EX-101.SCH 4155
3 XBRL DEFINITION FILE biot-20220503_def.xml EX-101.DEF 27494
4 XBRL LABEL FILE biot-20220503_lab.xml EX-101.LAB 37964
5 XBRL PRESENTATION FILE biot-20220503_pre.xml EX-101.PRE 26112
7 EXTRACTED XBRL INSTANCE DOCUMENT ea159623-8k425_biotech_htm.xml XML 7012
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 22905947
SIC: 2834 Pharmaceutical Preparations